Literature DB >> 36197582

Primary injection laryngoplasty after chordectomy for small glottic carcinomas.

Axelle Felicio-Briegel1, Kariem Sharaf2, Frank Haubner2, Matthias Echternach2.   

Abstract

OBJECTIVES: The purpose of this study was to analyze the short- and middle-term effects of primary injection laryngoplasty in patients having tumor resection within the same surgery concerning the vocal outcome. Injection laryngoplasty was performed after harvesting autologous adipose tissue via lipoaspiration.
METHODS: A prospective study was performed with 16 patients (2 female; 14 male) who received tumor resection and an injection laryngoplasty using autologous adipose tissue during a single stage procedure. Multidimensional voice evaluation including videostroboscopy, patient self-assessment, voice perception, aerodynamics, and acoustic parameters was performed preoperatively, as well as 1.5, 3 and 6 months postoperatively.
RESULTS: Results show an improvement in the roughness-breathiness-hoarseness (RBH) scale, voice dynamics and subjective voice perception 6 months postoperatively. Maintenance of Voice Handycap Index, jitter and shimmer could be observed 6 months postoperatively. There was no deterioration in RBH and subjective voice perception 2 and 6 weeks postoperatively. No complications occurred in the fat harvesting site.
CONCLUSIONS: Using the lipoaspiration and centrifugation approach, primary fat injection laryngoplasty shows short-term maintenance und middle-term improvement in voice quality in patients with vocal fold defect immediately after chordectomy 6 months postoperatively. Cancer recurrence rate is comparable to the reported cancer recurrence rate for laryngeal carcinoma and thus not elevated through primary augmentation.
© 2022. The Author(s).

Entities:  

Keywords:  Adipose-derived stem cells; Autologous adipose tissue; Chordectomy; Glottic cancer; Injection laryngoplasty; Voice outcome

Year:  2022        PMID: 36197582     DOI: 10.1007/s00405-022-07663-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   3.236


  37 in total

Review 1.  Functional outcomes after radiotherapy or laser surgery in early glottic carcinoma: a systematic review.

Authors:  Yda van Loon; Elisabeth V Sjögren; Ton P M Langeveld; Rob J Baatenburg de Jong; Jan W Schoones; Maya A van Rossum
Journal:  Head Neck       Date:  2011-09-30       Impact factor: 3.147

2.  Transoral laser microsurgery for Tis, T1, and T2 glottic carcinoma: 5-year follow-up.

Authors:  D De Seta; Flaminia Campo; V D'Aguanno; M Ralli; A Greco; F Y Russo; M de Vincentiis
Journal:  Lasers Med Sci       Date:  2020-05-29       Impact factor: 3.161

3.  A comparison of phonatory outcome between trans-oral CO2 Laser cordectomy and radiotherapy in T1 glottic cancer.

Authors:  Sachin Gandhi; Shashank Gupta; Govind Rajopadhye
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-29       Impact factor: 2.503

4.  Autologous Fat Augmentation in Post Type III Cordectomy Patients.

Authors:  Sachin Gandhi; Shashank Gupta; Nilanjan Bhowmick; Aniketh Pandurangi; Vrushali Desai
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-11-30

5.  Voice disorders in the general population: prevalence, risk factors, and occupational impact.

Authors:  Nelson Roy; Ray M Merrill; Steven D Gray; Elaine M Smith
Journal:  Laryngoscope       Date:  2005-11       Impact factor: 3.325

6.  Laryngeal cancer in Finland: A 5-year follow-up study of 366 patients.

Authors:  Aaro Haapaniemi; Petri Koivunen; Kauko Saarilahti; Ilpo Kinnunen; Jussi Laranne; Leena-Maija Aaltonen; Mervi Närkiö; Paula Lindholm; Reidar Grénman; Antti Mäkitie; Timo Atula
Journal:  Head Neck       Date:  2015-01-27       Impact factor: 3.147

Review 7.  Health status and voice outcome after treatment for T1a glottic carcinoma.

Authors:  A Jeanne G E Peeters; Christine D L van Gogh; Kim M Goor; Irma M Verdonck-de Leeuw; Johannes A Langendijk; Hans F Mahieu
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-01-09       Impact factor: 2.503

8.  Preoperative and postoperative voice in Tis-T1 glottic cancer treated by endoscopic cordectomy: an additional issue for patient counseling.

Authors:  Giorgio Peretti; Cesare Piazza; Cristiano Balzanelli; Maria C Mensi; Manuela Rossini; Antonino R Antonelli
Journal:  Ann Otol Rhinol Laryngol       Date:  2003-09       Impact factor: 1.547

9.  Prospective evaluation of voice outcome during the first two years in male patients treated by radiotherapy or laser surgery for T1a glottic carcinoma.

Authors:  Christine D L van Gogh; Irma M Verdonck-de Leeuw; Jeanne Wedler-Peeters; Johannes A Langendijk; Hans F Mahieu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-02-05       Impact factor: 2.503

10.  Laryngeal cancer: United Kingdom National Multidisciplinary guidelines.

Authors:  T M Jones; M De; B Foran; K Harrington; S Mortimore
Journal:  J Laryngol Otol       Date:  2016-05       Impact factor: 1.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.